NexGard Spectra- for most complete parasite protection in one tasty chew.
For the treatment and prevention of flea infestations, control of ticks and mites, prevention of heartworm, and treatment and control of intestinal worms in dogs and puppies from 8 weeks of age and 2 kilograms.
NexGard Spectra rapidly kills adult fleas and is indicated for the treatment and prevention of flea (Ctenocephalides spp.) infestations, for the control of newly acquired fleas and for the control of flea allergy dermatitis. Following administration, fleas are killed within 6-8 hours. Rapid onset of action kills newly acquired fleas before they can lay eggs. Fleas can transmit flea tapeworm (Diplyidium caninum). Effective flea control with NexGard Spectra prevents flea tapeworm infestations in dogs.
NexGard Spectra treat and controls Paralysis ticks (Ixodes holocyclus), Brown Dog ticks (Rhipicephalus sanguineus) and Bush ticks (Haemaphysalis longicornis) for one month. NexGard Spectra provides effective control of pre-existing Paralysis tick infestations within 24 hours. Ixodes holocyclus ticks do not occur in Western Australia. In tick season, daily searching for, and removal of, any ticks found is recommended.
NexGard Spectra treats and controls demodectic mane caused by Dermodex spp., sarcoptic mange caused by Sarcoptes scabiei and ear mite (Otodectes cynois) infestations.
NexGard Spectra prevents heartworm disease caused by Dirofilaria immitis and treats and controls roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum and A. ceylanicum) and whipworms (Trichuris vulpis). Consult a veterinarian if worm problems persist.
Monthly administration is recommended. Keep out of reach of children, read safety directions, for animal treatment only.
The recommended dosage for 15.1-30kg dogs is one 4g chewable (75mg afoxolaner; 15mg milbemycin oxime chewable) to deliver a minimum of 2.5mg of afozolaner per kg bodyweight and 0.5mg of milbemycin oxime per kg of bodyweight. Offer appropriate chewables(s) for your dog's weight at monthly intervals.
APVMA Approval No: 81012-102161